Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection.
Inhalation Delivery for the Treatment and Prevention of COVID-19 Infection.
复制标题
DOI:
10.3390/pharmaceutics13071077
复制
发表时间:
2021-07-14
期刊:
影响因子:
5.4
通讯作者:
Mansour HM
中科院分区:
文献类型:
--
作者:
Eedara BB;Alabsi W;Encinas-Basurto D;Polt R;Ledford JG;Mansour HM
Coronavirus disease-2019 (COVID-19) is caused by coronavirus-2 (SARS-CoV-2) and has produced a global pandemic. As of 22 June 2021, 178 million people have been affected worldwide, and 3.87 million people have died from COVID-19. According to the Centers for Disease Control and Prevention (CDC) of the United States, COVID-19 virus is primarily transmitted between people through respiratory droplets and contact routes. Since the location of initial infection and disease progression is primarily through the lungs, the inhalation delivery of drugs directly to the lungs may be the most appropriate route of administration for treating COVID-19. This review article aims to present possible inhalation therapeutics and vaccines for the treatment of COVID-19 symptoms. This review covers the comparison between SARS-CoV-2 and other coronaviruses such as SARS-CoV/MERS, inhalation therapeutics for the treatment of COVID-19 symptoms, and vaccines for preventing infection, as well as the current clinical status of inhaled therapeutics and vaccines.
登录
查看更多内容
影响因子:
3.7
作者:
Brunaugh AD;Seo H;Warnken Z;Ding L;Seo SH;Smyth HDC
通讯作者:
Smyth HDC
DOI:
10.1164/rccm.201312-2235oc
发表时间:
2014-07-15
影响因子:
24.7
作者:
Djukanovic, Ratko;Harrison, Tim;Monk, Phillip
通讯作者:
Monk, Phillip
影响因子:
16.1
作者:
Chung JY;Thone MN;Kwon YJ
通讯作者:
Kwon YJ
影响因子:
7.6
作者:
Caly, Leon;Druce, Julian D;Wagstaff, Kylie M
通讯作者:
Wagstaff, Kylie M
影响因子:
4.6
作者:
Eedara, Basanth Babu;Tucker, Ian G.;Das, Shyamal C.
通讯作者:
Das, Shyamal C.